Financhill
Sell
19

ELAN Quote, Financials, Valuation and Earnings

Last price:
$10.44
Seasonality move :
-1.47%
Day range:
$10.38 - $10.65
52-week range:
$10.03 - $18.80
Dividend yield:
0%
P/E ratio:
15.58x
P/S ratio:
1.17x
P/B ratio:
0.85x
Volume:
4.7M
Avg. volume:
4.9M
1-year change:
-33.71%
Market cap:
$5.2B
Revenue:
$4.4B
EPS (TTM):
$0.67

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ELAN
Elanco Animal Health
$1.2B $0.25 -2.17% 416.57% $15.42
AHCO
AdaptHealth
$808.2M $0.24 28.73% 111.44% $13.00
AXGN
Axogen
$53.4M $0.08 17.91% -76% $25.00
FULC
Fulcrum Therapeutics
-- -$0.32 -100% -24.42% $5.67
IART
Integra Lifesciences Holdings
$417M $0.57 3.33% 241.78% $26.25
OFIX
Orthofix Medical
$205.5M -$0.01 1.9% -75.79% $24.30
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ELAN
Elanco Animal Health
$10.44 $15.42 $5.2B 15.58x $0.00 0% 1.17x
AHCO
AdaptHealth
$9.61 $13.00 $1.3B 16.02x $0.00 0% 0.40x
AXGN
Axogen
$17.27 $25.00 $765.8M -- $0.00 0% 4.08x
FULC
Fulcrum Therapeutics
$3.12 $5.67 $168.4M -- $0.00 0% --
IART
Integra Lifesciences Holdings
$22.35 $26.25 $1.7B 70.14x $0.00 0% 1.07x
OFIX
Orthofix Medical
$16.53 $24.30 $645M -- $0.00 0% 0.79x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ELAN
Elanco Animal Health
41.48% 3.084 72.16% 1.03x
AHCO
AdaptHealth
55.77% 1.259 153.77% 0.91x
AXGN
Axogen
31.37% 0.673 6.53% 1.88x
FULC
Fulcrum Therapeutics
-- 0.964 -- 21.84x
IART
Integra Lifesciences Holdings
53.85% 2.847 103.03% 0.59x
OFIX
Orthofix Medical
23.79% 2.271 23.37% 1.29x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ELAN
Elanco Animal Health
$519M $8M 2.98% 5.48% -0.49% $124M
AHCO
AdaptHealth
$930.9M $76.7M 2.52% 6% 6.81% $73.1M
AXGN
Axogen
$37.6M $2M -6.89% -10.21% 4.56% $7.9M
FULC
Fulcrum Therapeutics
-- -$19.4M -8.07% -8.07% 65.62% -$17M
IART
Integra Lifesciences Holdings
$249.1M $35.6M -0.21% -0.45% 9.38% $11.2M
OFIX
Orthofix Medical
$148.8M -$10.8M -18.81% -22.96% -6.86% $15.2M

Elanco Animal Health vs. Competitors

  • Which has Higher Returns ELAN or AHCO?

    AdaptHealth has a net margin of -0.78% compared to Elanco Animal Health's net margin of 3.41%. Elanco Animal Health's return on equity of 5.48% beat AdaptHealth's return on equity of 6%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELAN
    Elanco Animal Health
    50.88% -$0.02 $10.4B
    AHCO
    AdaptHealth
    63.15% $0.34 $3.6B
  • What do Analysts Say About ELAN or AHCO?

    Elanco Animal Health has a consensus price target of $15.42, signalling upside risk potential of 47.67%. On the other hand AdaptHealth has an analysts' consensus of $13.00 which suggests that it could grow by 35.28%. Given that Elanco Animal Health has higher upside potential than AdaptHealth, analysts believe Elanco Animal Health is more attractive than AdaptHealth.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELAN
    Elanco Animal Health
    6 7 0
    AHCO
    AdaptHealth
    5 3 0
  • Is ELAN or AHCO More Risky?

    Elanco Animal Health has a beta of 1.439, which suggesting that the stock is 43.861% more volatile than S&P 500. In comparison AdaptHealth has a beta of 1.302, suggesting its more volatile than the S&P 500 by 30.157%.

  • Which is a Better Dividend Stock ELAN or AHCO?

    Elanco Animal Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AdaptHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elanco Animal Health pays -- of its earnings as a dividend. AdaptHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELAN or AHCO?

    Elanco Animal Health quarterly revenues are $1B, which are smaller than AdaptHealth quarterly revenues of $1.5B. Elanco Animal Health's net income of -$8M is lower than AdaptHealth's net income of $50.3M. Notably, Elanco Animal Health's price-to-earnings ratio is 15.58x while AdaptHealth's PE ratio is 16.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elanco Animal Health is 1.17x versus 0.40x for AdaptHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELAN
    Elanco Animal Health
    1.17x 15.58x $1B -$8M
    AHCO
    AdaptHealth
    0.40x 16.02x $1.5B $50.3M
  • Which has Higher Returns ELAN or AXGN?

    Axogen has a net margin of -0.78% compared to Elanco Animal Health's net margin of 0.91%. Elanco Animal Health's return on equity of 5.48% beat Axogen's return on equity of -10.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELAN
    Elanco Animal Health
    50.88% -$0.02 $10.4B
    AXGN
    Axogen
    76.06% $0.01 $151.4M
  • What do Analysts Say About ELAN or AXGN?

    Elanco Animal Health has a consensus price target of $15.42, signalling upside risk potential of 47.67%. On the other hand Axogen has an analysts' consensus of $25.00 which suggests that it could grow by 44.76%. Given that Elanco Animal Health has higher upside potential than Axogen, analysts believe Elanco Animal Health is more attractive than Axogen.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELAN
    Elanco Animal Health
    6 7 0
    AXGN
    Axogen
    4 0 0
  • Is ELAN or AXGN More Risky?

    Elanco Animal Health has a beta of 1.439, which suggesting that the stock is 43.861% more volatile than S&P 500. In comparison Axogen has a beta of 1.024, suggesting its more volatile than the S&P 500 by 2.388%.

  • Which is a Better Dividend Stock ELAN or AXGN?

    Elanco Animal Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elanco Animal Health pays -- of its earnings as a dividend. Axogen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELAN or AXGN?

    Elanco Animal Health quarterly revenues are $1B, which are larger than Axogen quarterly revenues of $49.4M. Elanco Animal Health's net income of -$8M is lower than Axogen's net income of $450K. Notably, Elanco Animal Health's price-to-earnings ratio is 15.58x while Axogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elanco Animal Health is 1.17x versus 4.08x for Axogen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELAN
    Elanco Animal Health
    1.17x 15.58x $1B -$8M
    AXGN
    Axogen
    4.08x -- $49.4M $450K
  • Which has Higher Returns ELAN or FULC?

    Fulcrum Therapeutics has a net margin of -0.78% compared to Elanco Animal Health's net margin of 69.26%. Elanco Animal Health's return on equity of 5.48% beat Fulcrum Therapeutics's return on equity of -8.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELAN
    Elanco Animal Health
    50.88% -$0.02 $10.4B
    FULC
    Fulcrum Therapeutics
    -- -$0.31 $273.8M
  • What do Analysts Say About ELAN or FULC?

    Elanco Animal Health has a consensus price target of $15.42, signalling upside risk potential of 47.67%. On the other hand Fulcrum Therapeutics has an analysts' consensus of $5.67 which suggests that it could grow by 81.62%. Given that Fulcrum Therapeutics has higher upside potential than Elanco Animal Health, analysts believe Fulcrum Therapeutics is more attractive than Elanco Animal Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELAN
    Elanco Animal Health
    6 7 0
    FULC
    Fulcrum Therapeutics
    1 4 0
  • Is ELAN or FULC More Risky?

    Elanco Animal Health has a beta of 1.439, which suggesting that the stock is 43.861% more volatile than S&P 500. In comparison Fulcrum Therapeutics has a beta of 2.198, suggesting its more volatile than the S&P 500 by 119.83%.

  • Which is a Better Dividend Stock ELAN or FULC?

    Elanco Animal Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fulcrum Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elanco Animal Health pays -- of its earnings as a dividend. Fulcrum Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELAN or FULC?

    Elanco Animal Health quarterly revenues are $1B, which are larger than Fulcrum Therapeutics quarterly revenues of $80M. Elanco Animal Health's net income of -$8M is higher than Fulcrum Therapeutics's net income of -$16.6M. Notably, Elanco Animal Health's price-to-earnings ratio is 15.58x while Fulcrum Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elanco Animal Health is 1.17x versus -- for Fulcrum Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELAN
    Elanco Animal Health
    1.17x 15.58x $1B -$8M
    FULC
    Fulcrum Therapeutics
    -- -- $80M -$16.6M
  • Which has Higher Returns ELAN or IART?

    Integra Lifesciences Holdings has a net margin of -0.78% compared to Elanco Animal Health's net margin of 4.39%. Elanco Animal Health's return on equity of 5.48% beat Integra Lifesciences Holdings's return on equity of -0.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELAN
    Elanco Animal Health
    50.88% -$0.02 $10.4B
    IART
    Integra Lifesciences Holdings
    56.27% $0.25 $3.3B
  • What do Analysts Say About ELAN or IART?

    Elanco Animal Health has a consensus price target of $15.42, signalling upside risk potential of 47.67%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $26.25 which suggests that it could grow by 17.45%. Given that Elanco Animal Health has higher upside potential than Integra Lifesciences Holdings, analysts believe Elanco Animal Health is more attractive than Integra Lifesciences Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELAN
    Elanco Animal Health
    6 7 0
    IART
    Integra Lifesciences Holdings
    1 6 2
  • Is ELAN or IART More Risky?

    Elanco Animal Health has a beta of 1.439, which suggesting that the stock is 43.861% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.861%.

  • Which is a Better Dividend Stock ELAN or IART?

    Elanco Animal Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elanco Animal Health pays -- of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELAN or IART?

    Elanco Animal Health quarterly revenues are $1B, which are larger than Integra Lifesciences Holdings quarterly revenues of $442.6M. Elanco Animal Health's net income of -$8M is lower than Integra Lifesciences Holdings's net income of $19.4M. Notably, Elanco Animal Health's price-to-earnings ratio is 15.58x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elanco Animal Health is 1.17x versus 1.07x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELAN
    Elanco Animal Health
    1.17x 15.58x $1B -$8M
    IART
    Integra Lifesciences Holdings
    1.07x 70.14x $442.6M $19.4M
  • Which has Higher Returns ELAN or OFIX?

    Orthofix Medical has a net margin of -0.78% compared to Elanco Animal Health's net margin of -13.52%. Elanco Animal Health's return on equity of 5.48% beat Orthofix Medical's return on equity of -22.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELAN
    Elanco Animal Health
    50.88% -$0.02 $10.4B
    OFIX
    Orthofix Medical
    69.02% -$0.75 $660.1M
  • What do Analysts Say About ELAN or OFIX?

    Elanco Animal Health has a consensus price target of $15.42, signalling upside risk potential of 47.67%. On the other hand Orthofix Medical has an analysts' consensus of $24.30 which suggests that it could grow by 47.01%. Given that Elanco Animal Health has higher upside potential than Orthofix Medical, analysts believe Elanco Animal Health is more attractive than Orthofix Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELAN
    Elanco Animal Health
    6 7 0
    OFIX
    Orthofix Medical
    3 2 0
  • Is ELAN or OFIX More Risky?

    Elanco Animal Health has a beta of 1.439, which suggesting that the stock is 43.861% more volatile than S&P 500. In comparison Orthofix Medical has a beta of 1.058, suggesting its more volatile than the S&P 500 by 5.812%.

  • Which is a Better Dividend Stock ELAN or OFIX?

    Elanco Animal Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Orthofix Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elanco Animal Health pays -- of its earnings as a dividend. Orthofix Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELAN or OFIX?

    Elanco Animal Health quarterly revenues are $1B, which are larger than Orthofix Medical quarterly revenues of $215.7M. Elanco Animal Health's net income of -$8M is higher than Orthofix Medical's net income of -$29.1M. Notably, Elanco Animal Health's price-to-earnings ratio is 15.58x while Orthofix Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elanco Animal Health is 1.17x versus 0.79x for Orthofix Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELAN
    Elanco Animal Health
    1.17x 15.58x $1B -$8M
    OFIX
    Orthofix Medical
    0.79x -- $215.7M -$29.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock